Quality assurance and continuous quality improvement in the management of vascular access

Contributions to Nephrology

Volumn 137, Issue , 2002, Pages 60-69

  Bosch, Juan P ^a,b   Walters, Brian A J ^a  

^a Scientific Affairs and Clinical Research   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; ARTICLE; HEALTH CARE QUALITY; HUMAN; QUALITY CONTROL; RENAL REPLACEMENT THERAPY; STANDARD; UNITED STATES;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RENAL DIALYSIS; UNITED STATES;

EID: 0036044462     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060232     Document Type: Article

References (14)

1. National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 1997;30(suppl 3):S150-S189.
2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access 2000. Am J Kidney Dis 2001;37(suppl 1):S137-S181.
3. Jindal KK, Ethier JH, Lindsay RM, Barre PE, Kappal JE, Carlisle EJF, Common A: Clinical practice guidelines for vascular access. J Am Soc Nephrol 1999;10:S287-S321.
4. HealthCare Financing Administration: 2000 Annual Report: ESRD Clinical Performance Measures Project. Am J Kidney Dis 2001;37(suppl 3):S1-S74.
5. Excerpts from the United States Renal Data System's 2001 Annual Data Report: Atlas of end stage renal disease in the United States. Am J Kidney Dis 2001;38(suppl 3):S79-S90.
6. Bleyer AJ, Rocco MV, Burkart JM: The costs of hospitalizations due to hemodialysis access management. Nephrol News Issues 1995;9:19-22.
7. Walters BAJ, Carter WB, Augustine BA, Bander SJ: Central venous catheters contribute to low blood hemoglobin in hemodialysis patients (abstract). J Am Soc Nephrol 2000;11:295A.
8. Walters BAJ, Molina M, Rosenthal RF, DiDominic V, Bander SJ: Incidence of bacteremia in hemodialysis patients 1993-1994 (abstract). J Am Soc Nephrol 1995;6:567.
9. Beserab A: Vascular access in Europe and the United States: Striking contrasts. Contemp Dial Nephrol 1999;20:22-28.
10. Astor BC, Eustace MB, Powe NR, Klag MJ, Sadler JJH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous fistulae use: The CHOICE study. Am J Kidney Dis 2001;38:494-501.
11. Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S, for the Hemodialysis (HEMO) Study Group: Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Kidney Int 2000;58:2178-2185.
12. Leypoldt KJ: Standards for reproducible access flow measurements. Blood Purif 2002;20:20-26.
13. Beserab A: Preventing vascular access dysfunction: Which policy to follow. Blood Purif 2002;20: 26-35.
14. Duda CR, Spergel LM, Holland J, Tucker T, Bander SJ, Bosch JP: How a multidisciplinary vascular access care program enables implementation of the DOQI guidelines. Nephrol News Issues 2000;14/5:13.